Brief: AcelRx Pharmaceuticals Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
03/12/2021 21:54
Dec 3 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS - RECEIVED NOTICE OF DELISTING OR
FAILURE
TO SATISFY A CONTINUED LISTING RULE OR STANDARD
* ACELRX PHARMACEUTICALS INC - WILL EVALUATE AVAILABLE
OPTIONS TO
REGAIN COMPLIANCE WITH THE MINIMUM BID PRICE REQUIREMENT
Further company coverage: ACRX.O
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial